Get the Daily Brief
Latest Biotech News
Regulatory and Industry Structural Developments
The biotech and healthcare sectors are navigating significant regulatory and structural shifts. Legal rulings have halted or challenged sweeping Department of Health and Human Services layoffs and...
Novel Diagnostic and Predictive Tools in Oncology
Advances in imaging and molecular diagnostics are enhancing cancer detection and management. Radiomics models combining CT imaging and AI improve preoperative differentiation of challenging liver...
Microbiome and Metabolic Research Impacting Health
Researchers are uncovering pivotal links between the microbiome and diverse health conditions. Engineered gut bacteria capable of detoxifying methylmercury demonstrate promise for reducing mercury...
Innovations in Enzyme Engineering and Synthetic Biology
Groundbreaking techniques harness automation, AI, and synthetic biology to accelerate and optimize enzyme design and protein production. University of Illinois researchers showcased an AI-powered...
Machine Learning and AI Models Enhance Disease Diagnosis and Management
Artificial intelligence and machine learning models are increasingly shaping diagnostic and therapeutic landscapes across diseases. Novel AI approaches predict breast cancer risk using biochemical...
Regulatory Landscape and AI Integration Challenges in Biomanufacturing
Regulatory agencies worldwide acknowledge the growing importance of artificial intelligence (AI) to enhance efficiency in drug development, manufacturing, and post-market oversight, yet clear...
FDA approves Regeneron bispecific antibody for multiple myeloma treatment
Regeneron Pharmaceuticals has secured FDA accelerated approval for Linvoseltamab (Lynozyfic), a bispecific antibody targeting BCMA and CD3, for adult patients with relapsed or refractory multiple...
Unnatural Products, Argenx partner on macrocyclic peptides targeting immune diseases
Unnatural Products Inc. has entered a multitarget research collaboration with Argenx SE to develop synthetic oral macrocyclic peptide drugs aimed at ‘undruggable’ immune disease targets. The...
AI-driven drug discovery reveals vorinostat as candidate for Rett syndrome treatment
Researchers at the Wyss Institute leveraged an AI-enabled drug prediction pipeline to identify vorinostat, an HDAC inhibitor approved for lymphoma, as a promising disease-modifying therapy for...
Genomic insights reveal chemotherapy’s mutational impact on healthy blood cells
A comprehensive genomic study by teams from the Wellcome Sanger Institute and University of Cambridge elucidates the distinct mutational signatures left by various chemotherapy agents on normal...
FDA and court actions delay Department of Health and Human Services restructuring
Federal courts in Rhode Island and other jurisdictions have issued preliminary injunctions halting parts of the Trump administration's sweeping Department of Health and Human Services (HHS)...
AI integration accelerates oncology diagnostics and clinical workflows
Adaptive Biotechnologies and Roche's Flatiron Health have partnered to integrate the ClonoSeq minimal residual disease (MRD) assay into Flatiron’s OncoEMR platform, facilitating ordering and...
Breakthrough glioblastoma therapy targets nonmuscle myosin to enhance treatment sensitivity
Researchers have developed MT-125, a nonmuscle myosin II inhibitor that penetrates the brain, effectively reduces glioblastoma invasiveness, and sensitizes resistant tumors to kinase inhibitors...
New machine learning models improve cancer prognosis and diagnostics
Researchers have unveiled advanced AI and machine learning models that enhance early diagnosis and prognosis prediction across various cancers. Notably, radiomics-based CT models differentiate...
Innovations in biomanufacturing accelerate gene and cell therapy production
Bioprocessing platforms are evolving toward modular, flexible, and automated systems to efficiently produce diverse gene-edited therapies at scale. Ori Biotech exemplifies this shift with...
Advances in sustainable materials and environmental biotech for health and agriculture
Recent breakthroughs in sustainable science include development of biodegradable cellulose foams mimicking bread baking, novel 3D-printable bioinks from drought-tolerant sorghum proteins, and gut...
Immunotherapy Advances in Liver Cancer: Dual vs Monotherapy Approaches
Recent clinical studies have highlighted significant progress in immunotherapy for hepatocellular carcinoma (HCC). One multicentric investigation across India confirmed the safety and efficacy of...
Innovations in Glioblastoma Treatment: Targeted Drugs and Microbiome Influence
Glioblastoma remains a formidable brain tumor with limited effective treatments. Researchers have identified new therapeutic candidates such as MT-125, a compound that inhibits non-muscle myosin...
AI and Machine Learning Empower Cancer Diagnosis and Prognosis
Artificial intelligence (AI) is increasingly integrated into oncology for improving early detection and disease management. A new machine learning model developed at the University of Sharjah...
Advancements in 3D Printing and Bioink Materials for Food and Pharmaceuticals
Recent breakthroughs exploit novel material bases for 3D printing applications in food and medicine. Sorghum proteins, known for their drought resistance and hydrophobic properties, have been...